Capsugel Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Capsugel Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013189
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the bioavailability, targeted delivery and overall performance of their products. Capsugel partners with numerous customers in several countries to create novel, high-quality and customized solutions that align with its customers’ evolving needs and benefit consumers and patients. The company has 13 manufacturing sites and three research and development centers in nine countries across three continents. Capsugel is headquartered in Morristown, New Jersey, the US.

Capsugel Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Capsugel Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Capsugel Inc, Medical Devices Deals, 2011 to YTD 2017 9
Capsugel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Capsugel Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Capsugel Acquires Ionic Liquids Technology from Monash University 11
Capsugel Acquires FlexTab Technology From GlaxoSmithKline 12
Private Equity 13
Kohlberg Kravis Completes Acquisition Of Capsugel From Pfizer 13
Partnerships 15
Capsugel Enters into Agreement with Pulmatrix 15
Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 16
Quotient Clinical Enters Into Co-Development Agreement With Capsugel 17
Catalent Pharma Solutions Enters Into Agreement With Bend Research 18
Encap Drug Delivery Enters Into Co-Development Agreement With Lena Nanoceutics 19
Bend Research Enters Into An Agreement With Xcelience 20
Critical Outcome Technologies and Xcelience Enter into Agreement 21
Licensing Agreements 22
Bend Research Enters Into Licensing Agreement With Affinium For SDD Technology 22
Bend Research Enters Into Licensing Agreement With Eli Lilly For SDD Technology 23
Bend Research Enters Into Licensing Agreement With Merck 24
Acquisition 25
Lonza Acquires Capsugel from KKR & Co for USD5.5 Billion 25
Capsugel Acquires Xcelience 27
Capsugel Completes Acquisition Of Bend Research, Drug Delivery Technologies Company 28
Capsugel Belgium Acquires Encap Drug Delivery 29
Capsugel Inc – Key Competitors 30
Capsugel Inc – Key Employees 31
Capsugel Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 35
Strategy And Business Planning 35
Oct 03, 2016: Capsugel Expands Capabilities for Early-Phase Development through Commercial Manufacturing across Multiple Locations in Europe 35
Other Significant Developments 36
Sep 07, 2016: Capsugel Investing in Enhanced Micronization Capacity and Capabilities 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Capsugel Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Capsugel Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Capsugel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Capsugel Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Capsugel Inc, Medical Devices Deals, 2011 to YTD 2017 9
Capsugel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Capsugel Acquires Ionic Liquids Technology from Monash University 11
Capsugel Acquires FlexTab Technology From GlaxoSmithKline 12
Kohlberg Kravis Completes Acquisition Of Capsugel From Pfizer 13
Capsugel Enters into Agreement with Pulmatrix 15
Capsugel Enter into Co-Development Agreement with Cardax for Astaxanthin Products 16
Quotient Clinical Enters Into Co-Development Agreement With Capsugel 17
Catalent Pharma Solutions Enters Into Agreement With Bend Research 18
Encap Drug Delivery Enters Into Co-Development Agreement With Lena Nanoceutics 19
Bend Research Enters Into An Agreement With Xcelience 20
Critical Outcome Technologies and Xcelience Enter into Agreement 21
Bend Research Enters Into Licensing Agreement With Affinium For SDD Technology 22
Bend Research Enters Into Licensing Agreement With Eli Lilly For SDD Technology 23
Bend Research Enters Into Licensing Agreement With Merck 24
Lonza Acquires Capsugel from KKR & Co for USD5.5 Billion 25
Capsugel Acquires Xcelience 27
Capsugel Completes Acquisition Of Bend Research, Drug Delivery Technologies Company 28
Capsugel Belgium Acquires Encap Drug Delivery 29
Capsugel Inc, Key Competitors 30
Capsugel Inc, Key Employees 31
Capsugel Inc, Other Locations 32
Capsugel Inc, Subsidiaries 33

★海外企業調査レポート[Capsugel Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BoneSupport AB:企業の製品パイプライン分析2018
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infect …
  • Nippon Shokubai Co Ltd (4114):企業の財務・戦略的SWOT分析
    Nippon Shokubai Co Ltd (4114) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Petroleos Mexicanos:企業の戦略・SWOT・財務情報
    Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report Summary Petroleos Mexicanos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CoreLogic Inc (CLGX):企業の財務・戦略的SWOT分析
    CoreLogic Inc (CLGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Great Basin Scientific Inc (GBSN):製品パイプライン分析
    Summary Great Basin Scientific Inc (Great Basin) is a molecular diagnostics company that offers technology products. The company develops and distributes point-of-care technology and products to improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing. It …
  • GS Energy Corp-エネルギー分野:企業M&A・提携分析
    Summary GS Energy Corp (GS Energy) is an energy holding company that manufactures and markets transportation fuels. The company's services include exploration and production, green growth, gas and electric power, refining and petrochemicals. It's refining and petrochemicals services comprise manufac …
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Saudi Arabian Mining Co:戦略・SWOT・企業財務分析
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sopharma AD (3JR):企業の財務・戦略的SWOT分析
    Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sohar Aluminium LLC:企業の戦略・SWOT・財務情報
    Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report Summary Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Chesapeake Energy Corp (CHK):企業の財務・戦略的SWOT分析
    Chesapeake Energy Corp (CHK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Texwinca Holdings Limited:企業の戦略・SWOT・財務分析
    Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BioMoti Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BioMoti Ltd (BioMoti) is a pharmaceutical company that offers cancer therapeutics that develops platform drug delivery technologies. The company provides products such as Oncojans a class of immunotherapeutic drug-loaded particles to target and gain entry into the tumour vasculature and canc …
  • Bob Evans Farms, Inc.:企業の戦略・SWOT・財務情報
    Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Nerviano Medical Sciences Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Nerviano Medical Sciences Srl (NMS) is a drug development company that discovers and develops novel anticancer drugs. The company's pipeline products include anticancer compounds such as Danusertib, Encorafenib, Entrectinib, ADC Payload programs, PARP1 program, NMS-088, Brostallicin, Milcicl …
  • Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression t …
  • PT Elnusa Tbk (ELSA):企業の財務・戦略的SWOT分析
    Summary PT Elnusa Tbk (PT Elnusa), a subsidiary of PT Pertamina (Persero), is an oil and gas company that offers geo science services, and drilling and oilfield services. The company's geo science services include seismic data acquisition, seismic data measurement, seismic data processing, and non s …
  • Mars, Incorporated:企業の戦略・SWOT・財務情報
    Mars, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Mars, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆